{ "items": [ "\n\n
\n \n 28 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nMicroscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.
\n \n\n\n \n 20 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n LOMWRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nEncephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.
\n \n\n\n \n 7 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nDavid Warrell, MORU founding director, has been appointed by the Queen \u2018Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice\u2019. Please join us in congratulating Sir David on receiving this richly deserved high honour!
\n \n\n\n \n 11 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n LOMWRU\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nOrganised by a grass-root community of thousands of scientists across the world, Pint of Science 2022 allows researchers in 25 countries and over 800 cities to share their latest findings with lay folk in interesting, informal settings. Lao PDR joined the global Pint of Science family on Monday 9 May, when the first-ever Pint of Science Laos kicked off!
\n \n\n\n \n 25 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nToday is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.
\n \n\n\n \n 22 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n COMRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nIn regions where few people have received Covid-19 vaccines, health systems remain vulnerable to surges in SARS-CoV-2 infections. During the delta-wave of COVID-19 in India, for example, healthcare facilities and staff across the country struggled to cope with the surge in the number of cases of COVID-19 due to a shortage of hospital beds for people with severe cases, plus shortages of medicines and limited human resources.
\n \n\n\n \n 24 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nIn 2022, tuberculosis (TB) remains a major global health problem, particularly in developing countries. On the Thai-Myanmar border, TB is an important problem among migrants, a vulnerable, very mobile population, with unstable, often difficult living conditions, insecure incomes, and poor access to health services.
\n \n\n\n \n 22 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nA triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.
\n \n\n\n \n 25 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nFrom 2002-2018, there has been a steady increase in the places and proportion of infected people reporting validated kelch13 (K13) artemisinin resistance markers, according to a study in The Lancet Microbe. This increase in artemisinin resistance threatens efforts to eliminate malaria in Asia by 2030 \u2014 and control efforts in other endemic regions. The authors say that more consistent data collection, over longer time periods in the same areas, and rapid sharing of data are needed to map the spread of resistance and better inform policy decisions.
\n \n\n\n \n 20 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nAntimicrobial resistance (AMR) is responsible for at least 1.27 million deaths per year \u2014 with over 97,000 deaths in 2019 in SE Asia alone, according to a study published in The Lancet by the Global Research on AntiMicrobial resistance (GRAM) project, who urged urgent action from policymakers and health communities to avoid further preventable deaths.
\n \n\n\n \n 20 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n COMRU\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nIn the 2021 Oxford Recognition of Distinction round, four MORU colleagues were awarded Full Professor title.
\n \n\n\n \n 24 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nFeatured in Nature, Victor Chaumeau collects mosquitoes in Myanmar to better understand how to control malaria.
\n \n\n\n \n 24 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nPatients in north Africa and the Middle East are using antibiotics in sharply rising quantities far beyond the global average, raising concerns over the escalating risks of resistance to medicines to treat bacterial infections. Estimated antibiotic consumption for 204 countries between 2000 and 2018 shows a 46 per cent increase in global antibiotic usage, with a surge in nations including India and Vietnam.
\n \n\n\n \n 19 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nA downloadable resource for educators, health & research professionals to help develop young peoples\u2019 understanding of AMR and positive actions they can take to mitigate it.
\n \n\n\n \n 18 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nTo mark WHO World Antimicrobial Awareness Week, 18-24 Nov 2021, and help reduce the overuse of antibiotics, MORU researchers have released a new, easy to use online tool \u2013 Antibiotic Footprint Calculator \u2013 that could make an important contribution in the fight against antimicrobial resistance (AMR), one of the world\u2019s most significant emerging threats to public health.
\n \n\n\n \n 12 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nGlobal antibiotic consumption rates increased by 46 percent in the last two decades, according to the first study to provide longitudinal estimates for human antibiotic consumption covering 204 countries from 2000 to 2018, published in Lancet Planetary Health by the Global Research on Antimicrobial Resistance (GRAM) Project.
\n \n\n\n \n 11 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n LOMWRU\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nA series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.
\n \n\n\n \n 22 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nEvery year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (NDM-CGHR) as second year DPhil student. Our warmest congratulations to you all!
\n \n\n\n \n 21 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nThere are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.
\n \n\n\n \n 14 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nFollowing the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor
\n \n\n\n \n 30 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nA 6-week recruitment burst at Aga Khan University in Pakistan led the way as COPCOV enrolment broke 1600 participants. Led by MORU, COPCOV is the world\u2019s largest trial trying to determine if hydroxychloroquine and chloroquine prevent COVID-19.
\n \n\n\n \n 21 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nAn international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues report the unequal impacts of public health measures, and the prevalence of \u2018fake news\u2019.
\n \n\n\n \n 9 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nAs high COVID-19 daily cases and highly transmissible variants risk overwhelming countries\u2019 healthcare systems, COPCOV, the world\u2019s last-standing large prophylaxis RCT, faces tight timelines to determine whether chloroquine/ hydroxychloroquine prevents COVID-19
\n \n\n\n \n 8 July 2021\n \n
\n\n \n\n \n\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nAbout one-third of children diagnosed with severe malaria may instead have an alternative cause of illness, but simple blood tests could help researchers distinguish between the two and speed up research on new treatments.
\n \n\n\n \n 8 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n \n \nMalaria continues to be a major killer, particularly in sub-Saharan Africa, affecting the world\u2019s most vulnerable populations with more than 500,000 deaths per year, most of them African children. Emergence of resistance to antimalarial drugs is major public health issue. American Society for Microbiology Editor Dr Cesar Arias discusses with Professor Sir Nick White the latest information on this rapidly evolving field.
\n \n\n\n \n 19 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nWhich infections are most common in the Chiangrai region? How should we treat them and how can we improve diagnostic? Which strategies are most effective in directing antibiotic treatment? Blog by Carlo Perrone, research physician based at the Chiang Rai Clinical Research Unit in Chiangrai, Thailand.
\n \n\n\n \n 12 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \n\"Although it is hard to look beyond the pandemic right now,\" says President of the Academy of Medical Sciences Professor Dame Anne Johnson, \"I want to stress how important it is that the Academy Fellowship represents the widest diversity of biomedical and health sciences. The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration.\"
\n \n\n\n \n 7 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nLive and on-line from Bangkok! Be ready for Thursday 13th May, when Pint of Science Thailand will stream live from Bangkok. Join us via Facebook, YouTube or right here from the Pint of Science Thailand website as we journey from bacterial infections to viruses, discover how clinical trials work, and how scientific development is seen in the eyes of the law!
\n \n\n\n \n 25 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nFor World Malaria Day 2021, F1000 Research Blog spoke to Professor Phaik Yeong Cheah about her research focussed on drama and arts-based community engagement for malaria research, published with Wellcome Open Research.
\n \n\n\n \n 23 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nOn Sunday 25 April, World Malaria Day, the Developing Paediatric Primaquine (DPP) project will launch its website. DPP will produce children-appropriate primaquine doses that could both cut malaria deaths in vulnerable African children by blocking transmission of P. falciparum malaria and reduce P. vivax malaria more widely.
\n \n\n\n \n 16 March 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Medicine Quality Research Group has published a new Medical Product Quality Report focussing on increasing issues around substandard and falsified (SF) COVID-19 vaccines. With the implementation of the key innovations of COVID-19 vaccines, there have been growing numbers of reports of SF vaccines in the public domain. Given the vital role they will play in ending the pandemic and protecting the global population but severe issues with equitable access, SF vaccines are highly likely to be a growing problem.
\n \n\n\n \n 2 February 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Indonesian government policy to exclude the elderly in the first phase of the COVID-19 vaccination program could hinder the vaccine\u2019s impact in lowering mortality rates. COVID-19 mortality rates in Indonesia, the highest in Southeast Asia, are dominated by those in the 60 years and above age bracket. In this article published in The Conversation, Kartika Saraswati and fellow DPhil students elaborate how, by prioritising vaccination for elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amidst a limited vaccine supply during the first vaccination phase.
\n \n\n\n \n 13 January 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nA study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.
\n \n\n\n \n 7 December 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nBlog by Rima Shretta. Preliminary efficacy results from three vaccine candidates currently in Phase 3 trials have shown an efficacy of more than 90% against the development of symptomatic COVID-19. While these results are promising, all vaccines are in relatively early stages of testing. A comprehensive and transparent roadmap is urgently needed, to determine how limited doses of the first vaccines to be licensed will be distributed, together with which groups will initially be prioritized.
\n \n\n\n \n 1 December 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study quantifying the high risk of Plasmodium vivax parasitaemia after treatment of Plasmodium falciparum malaria aims to identify populations in which a policy of universal radical cure, combining artemisinin-based combination therapy with a hypnozoitocidal antimalarial drug, would be most beneficial.
\n \n\n\n \n 23 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Clare Ling has been made an honorary Fellow of the Royal College of Pathologists (FRCPath). Currently running Shoklo Malaria Research Unit (SMRU) Microbiology department and supporting the unit\u2019s molecular activities, Clare is a clinical scientist who has worked at SMRU on the Thai-Myanmar border since 2012.
\n \n\n\n \n 18 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nAs the world anxiously awaits COVID-19 vaccines, people working in healthcare settings remain at risk of infection from COVID-19. The Pakistani arm of COPCOV, the global study to test if hydroxychloroquine or chloroquine can prevent COVID-19 in healthcare workers, has begun to enrol participants at Aga Khan University, joining sites in the UK and Thailand.
\n \n\n\n \n 11 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nIn an effort to foster closer interactions and collaboration, CTMGH learned long ago to make the best of the plethora of communication tools available. In this era of video conferences, we are all familiar with the limitations of various 2D options. Could new technologies help us devise better communication to enhance collaboration and teaching opportunities? In an effort to find new solutions, a group of NDM staff visited London and interacted as a hologram with colleagues in Bangkok.
\n \n\n\n \n 9 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n LOMWRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to everyone involved in contributing to FIEBRE\u2019s success - the clinical and laboratory staff, hospital, participants and local communities. The team has continued working throughout the COVID-19 epidemic despite national restrictions which slowed down enrolment and limited field activities.
\n \n\n\n \n 5 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nIn the next few months, the first Phase 3 COVID-19 vaccine trials \u2013 the majority of them in upper-middle or high-income countries and in specific target populations like young adults \u2013 will report their results. How relevant will their study results be for low-resource settings?
\n \n\n\n \n 30 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nEthox programme REACH (Resilience, Empowerment and Advocacy in Women's and Children's Health Research) posted a visual research gallery as a Public Engagement project. Six galleries of photos by SMRU's Suphak Nosten depict aspects of migrant workers' daily lives: the Thai-Myanmar border; work; cultural and spiritual values; the often-difficult journeys seeking healthcare; striving for better; and dedicated frontline health workers. Richly coloured, sometimes personal, Suphak\u2019s photography is deeply empathetic and memorable.
\n \n\n\n \n 30 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n LOMWRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has awarded CTMGH two new Professors. Elisabeth Ashley - UK-trained physician who specialises in infectious diseases and medical microbiology & virology, and Director of the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) in Lao PDR since 2019, Liz is conferred the title of Professor of Tropical Medicine. Stuart Blacksell - Senior Research Scientist based at the Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Thailand, Stuart is conferred the title of Professor of Tropical Microbiology.
\n \n\n\n \n 28 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are pleased to announce that Prof Joel Tarning has been awarded the biennial Grahame-Smith Prize by the British Pharmacological Society for outstanding contributions to clinical pharmacology. Joel has headed MORU's Clinical Pharmacology Department since 2012. Since then, the Department has grown into large, productive group that conducts laboratory- and computer-based pharmacology research.
\n \n\n\n \n 23 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford is world-famous for research excellence and home to some of the most talented people from across the globe. To showcase our global research, the University launched a Global Research Map, highlighting areas of research we are conducting overseas.
\n \n\n\n \n 14 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford, MORU, the University of Cape Town, the Thai Ministry of Public Health, and UNICEF Thailand worked together to promote lifelong health and well-being, and prevent violence against children. Led by Amalee McCoy from MORU Department of Bioethics & Engagement, this project involved the cultural adaptation and testing of an evidence-based parenting intervention for low-income families with children aged 2-9 living in Udon Thani, Thailand.
\n \n\n\n \n 14 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MOCRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nMORU\u2019s Mo Yin and MOCRU\u2019s Myo Maung Maung Swe were awarded a prize by the NDM\u2019s Graduate Studies Committee. Very competitive awards, the prizes are given annually to current or recently graduated students of NDM supervisors on the basis of their publication record, the impact and novelty of their research, references, and research within their department.
\n \n\n\n \n 15 September 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are delighted to announce that Professor Paul Newton has won the Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research. This award is based on the scientific merit of his work, as well as its impact on patients, decisions makers, and on governments. It recognizes the talents of exceptional researchers who are making a significant contribution to the field of pharmaceutical policy and practice.
\n \n\n\n \n 10 September 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n \n \nResearch Malaria Microscopy Standards (ReMMS) applicable to malaria clinical research studies have been published in Malaria Journal. The paper describes the rationale for proposed standards to prepare, stain and examine blood films for malaria parasites.
\n \n\n\n \n 10 September 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nAs the world waits impatiently for a COVID-19 vaccine, an exhaustive review of hydroxychloroquine and chloroquine pharmacology suggests that the doses used in COVID-19 prevention trials are safe, say University of Oxford affiliated researchers in a study published in PLoS Medicine.
\n \n\n\n \n 6 August 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n \n \nHydroxychloroquine could still prevent COVID-19 and save tens of thousands of lives around the world, say leading scientific researchers. While it doesn\u2019t work in treatment of hospitalised patients, it could still prevent infections. However, fraudulent data, unjustified extrapolation and exaggerated safety concerns together with intense politicisation and negative publicity may stop COPCOV, the only large, global clinical trial testing hydroxychloroquine in COVID-19 prevention, from ever finding out.
\n \n\n